Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
6.84
-0.10 (-1.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed
MRVI Market Cap
MRVI has a market cap or net worth of $908.56 million as of July 2, 2024. Its market cap has decreased by -72.30% in one year.
Market Cap
908.56M
Enterprise Value
902.59M
1-Year Change
-72.30%
Ranking
Category
Stock Price
$6.84
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $908.56M, a decrease of -87.44%. That is a compound annual growth rate of -43.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.75B | 6.23% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 923.55M |
| Cullinan Oncology | 918.40M |
| Autolus Therapeutics | 911.17M |
| Liquidia | 910.93M |
| Avanos Medical | 902.47M |
| Centessa Pharmaceuticals | 896.30M |
| Rapport Therapeutics | 890.60M |
| ARS Pharmaceuticals | 872.06M |